Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Forge Stronger Partnership for Advanced ADC Development! GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs 2023-07-07 10:19
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris has Completed the Phase III bridging trial Enrollment 2023-07-06 18:33
CARING PHARMACY CELEBRATES UNIFIED CARING MEMBERSHIP PROGRAMME WITH GEORGETOWN PHARMACY AND WELLINGS PHARMACY 2023-07-06 18:00
Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China 2023-07-06 10:38
MGI's DNBSEQ-T7* Receives Approval for Clinical Use in South Korea 2023-07-06 09:00
Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure 2023-07-06 07:25
Brii Biosciences Provides Latest Clinical Development and Corporate Updates 2023-07-06 07:19
Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President and Head of Business Development 2023-07-05 22:05
TiumBio and Hansoh Pharma Announce Clinical Trial Approval of 'HS-10518/TU2670' from NMPA in China 2023-07-05 20:00
I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC 2023-07-05 20:00
Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China 2023-07-04 21:16
China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy 2023-07-04 20:42
AFTER FIVE YEARS OF SUCCESSFUL EXPERIENCE INTERNATIONALLY, BIOCON BIOLOGICS' HULIO® BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES 2023-07-04 01:22
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration 2023-07-03 19:00
Henlius Forecasts Profit in 1H 2023 2023-07-03 18:59
Henlius Forecasts Profit in 1H 2023 2023-07-03 17:49
SHL Medical acquires 100% of the shares in Swiss company LCA Automation 2023-07-03 17:00
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease 2023-07-03 08:00
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma 2023-07-03 08:00
Lifera and CENTOGENE, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing 2023-07-02 14:00
1 93 94 95 96 97 413